Patent · US Active

Therapeutic agents

US11802143B2 · kind B2 · utility

0Cited by
7References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 10, 2020
Grant dateOct 31, 2023
Priority date
Expiry dateDec 29, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An immunoresponsive cell, such as a T-cell expressing This arrangement is referred to as parallel chimeric activating receptors (pCAR). Cells of this type are useful in therapy, and kits and methods for using them as well as methods for preparing them are described and claimed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.